ANGELA LOWE: Open Payments
NPI 1649569666 · BELLEVUE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 23 payments from 8 companies in 2025. Trend: 2023 $220 · 2024 $299 · 2025 $387
Food & beverage: $298Education: $88
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $160 |
| Teva Pharmaceuticals USA, Inc. | 1 | $88 |
| Alexion Pharmaceuticals, Inc. | 1 | $32 |
| Biogen, Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Celgene Corporation | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $17 |
| ARGENX US, INC. | 1 | $17 |
Products named: UBRELVY, QULIPTA, ULTOMIRIS, TYSABRI, KESIMPTA, ZEPOSIA, TREMFYA, VYVGART HYTRULO.
Industry payments across OH — which companies pay providers there.
